|31st October 2018
Blue Latitude Health’s mission is to unlock the potential in products and services that save and transform lives. We work with companies and organisations who bring innovation to healthcare and are proud to announce that we have joined the Personalized Medicine Coalition (PMC), as one of their strategic partners.
The Personalized Medicine Coalition (PMC), set up in 2004, represents innovators, scientists, patients, providers and payers to promote the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. Based out of Washington DC, the PMC provide opinion leadership on policy issues that affect personalized medicine; help educate policymakers in government, industry and academia about the benefits of personalized medicine; and serve as a forum for identifying and informing others of policies that could advance or impede the development of personalized medicine.
As a creative consultancy, made for modern healthcare, Blue Latitude Health, have extensive, end-to-end experience of launching breakthrough therapies and precision medicines; helping our global clients to map future customer and patient needs and develop and execute commercial strategies against these needs.
Fred Bassett, Co-founder and Head of Strategy said ‘’Personalized Medicine is transforming the practice of medicine. However across a broad spectrum of healthcare stakeholders, significant challenges remain. We are excited to join the PMC who are playing a critical role in bringing together all of the stakeholders to advocate for changes that will increase investment in personalized medicine and facilitate its adoption.’’
David Cooney, Senior Consultant, and Sophie Berger, Senior Marketing and Business Development Manager, will be attending the 14th Annual Personalized Medicine Conference, taking place at Harvard Medical School from the 14th – 15th of November 2018. The conference will examine the infrastructure and business strategies necessary to overcome scientific obstacles, optimize public policies, and change embedded medical norms as the industry ‘Prepares for the New Possible’.
For those who cannot attend the conference, we continue to publish thought leadership around the topic, including our Perspective magazine ‘Precision Medicine Starts Here’ and articles with leaders in the field including: medical information trail blazers and genetics experts. If you are attending the conference or interested in any topics relating to Personalized Medicine, please contact email@example.com or firstname.lastname@example.org.